Anika Therapeutics (ANIK) Change in Cash (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Change in Cash data on file, last reported at -$16.5 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 334.56% year-over-year to -$16.5 million in Q1 2026; TTM through Mar 2026 was -$12.4 million, a 19.05% increase from a year earlier, with the FY2025 full-year figure at $322000.0, up 102.05% from the prior year.
• Change in Cash for Q1 2026 stood at -$16.5 million, down from -$509000.0 in the prior quarter.
• Over the last five years, Change in Cash for ANIK reached as high as $5.6 million in Q3 2023 and fell as low as -$16.5 million in Q1 2026.
• Historically, Change in Cash has averaged -$3.1 million across 5 years, with a median of -$3.6 million in 2022.
• Across the five-year window, Change in Cash slumped 1474.51% in 2023 and soared 1162.33% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$1.4 million in 2022, then soared by 252.83% to $2.2 million in 2023, then slumped by 335.06% to -$5.2 million in 2024, then jumped by 90.23% to -$509000.0 in 2025, then slumped by 3133.99% to -$16.5 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$16.5 million in Q1 2026, -$509000.0 in Q4 2025, and $4.8 million in Q3 2025.